Sponsor:
Boston Sight
Code:
NCT07195721
Conditions
Depression - Major Depressive Disorder
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Depression - Major Depressive Disorder
Study ID
NCT07195721
Start date
Nov 11, 2024
Status verified date
Oct, 2025
Completion date
Oct 31, 2029
Anticipated
Primary completion date
Oct 31, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Arms
Patients who are considering PROSE treatment for ocular surface disease
Primary outcome measure
Central contacts
Locations
BostonSight
Recruiting
Needham, Massachusetts, United States, 02494
Contacts
Principal Investigator:
Daniel Brocks, MD
Sponsor
Boston Sight
Last update posted
Jan 5, 2026
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Sight on 2026-01-05.